Australia’s bet on artificial intelligence in healthcare is entering a new and complicated phase. Just a year after the federal government invested $32 million in Harrison (dot) ai as part of a funding round intended to help the company grow from Australia, the health-tech startup is restructuring its Australian workforce while expanding into the United States with a new business that employs American doctors to use its AI technology, states a news report by ABC News. Founded by brothers Aengus and Dimitry Tran in 2018, Harrison (dot) ai develops artificial intelligence tools designed to assist doctors in interpreting medical scans, particularly radiology images. According to the news report, the company says its technology is now used by about 3,500 clinicians across more than 1,000 sites and its investors include major Australian healthcare companies such as I-MED and Sonic Healthcare, alongside venture capital firm Blackbird.For the uninitiated, Harrison (dot) ai was valued at close to $400 million during a 2025 fundraising round. The federal government’s National Reconstruction Fund Corporation contributed $32 million, supporting the company’s ambitions to scale internationally while maintaining its base in Australia. But the company’s next phase is bringing significant changes at home. Scroll down to read the details.
Australian jobs cut as AI strategy changes
Earlier this year, Harrison (dot) ai informed Australian employees that some positions would be made redundant. An internal document seen by the ABC showed affected workers were told in April that the company would undergo a consultation process before final decisions were made. At least two employees subsequently announced on LinkedIn that their positions had been made redundant. As per the report, the restructuring is linked to a broader shift in how Harrison.ai intends to operate. The company is moving towards a model in which employees are expected to manage fleets of increasingly autonomous AI agents, effectively combining traditional roles with responsibility for overseeing AI systems. Company leadership has indicated that the transformation has also prompted some employees to leave because they preferred more conventional workplace structures. The National Reconstruction Fund Corporation has acknowledged the job cuts, describing the company’s transition as a move from product development towards commercialisation and international deployment.
A new US business model
At the same time, Harrison (dot) ai is expanding its presence in the United States through Frontier Radiology, an AI-enabled teleradiology service that hires US radiologists to interpret scans using Harrison (dot) ai’s technology. Accordig to the ABC News report, Frontier describes itself as an independent medical practice affiliated and partnered with Harrison (dot) ai, which provides administrative, operational and technological support. The new model has raised questions about potential conflicts of interest. Frontier’s doctors are being recruited to use technology developed by a company with which the service is closely affiliated. Its recruitment materials include a payment calculator that factors in the expected productivity gains from Harrison.ai’s AI. The model assumes doctors using the technology can become 30 per cent more productive, with an additional bonus tied to the extra work attributed to AI assistance. That arrangement has prompted concerns over whether doctors will always feel free to challenge AI-generated recommendations when they believe those recommendations are wrong.
Earlier privacy scrutiny adds another layer
Harrison (dot) ai has previously faced scrutiny over the data used to train its systems. Millions of medical scans supplied by I-MED were used for AI development after being de-identified. I-MED said the scans had been sufficiently de-identified, but patients were not directly notified or asked for consent.An investigation by Australia’s privacy regulator ultimately accepted that the information had been adequately de-identified and closed its inquiries. Separately, government documents later revealed that the Department of Health and Aged Care had briefed the health minister’s office about concerns surrounding the use of medical scans for AI training.
Global ambitions, Australian questions
Harrison (dot) ai now appears focused on turning its technology into a global healthcare business, with signs that it is also preparing for a possible ASX listing. The company’s transformation raises a broader question for Australia’s AI strategy: how should public investment balance the goal of building globally competitive technology companies with expectations around Australian jobs, healthcare data and domestic economic benefits? For them, the next stage may prove whether an Australian-founded health-AI company can scale globally while delivering on the domestic promise that helped attract public funding in the first place.Images Courtesy: istock
